Global Celiac Diseases Drugs Market 2023-2027

1.1 Market overview

• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2.1 Market ecosystem

• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3.1 Market definition

• Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis

• Exhibit 13: Market segments

3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027

• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4.1 Global celiac diseases drugs market 2017 - 2021

• Exhibit 18: Historic Market Size - Data Table on global celiac diseases drugs market 2017 - 2021 ($ million)

4.2 Therapy Segment Analysis 2017 - 2021

• Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)

4.3 Route of Administration Segment Analysis 2017 - 2021

• Exhibit 20: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)

4.4 Geography Segment Analysis 2017 - 2021

• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)

4.5 Country Segment Analysis 2017 - 2021

• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5.1 Five forces summary

• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers

• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers

• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027

5.4 Threat of new entrants

• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027

5.5 Threat of substitutes

• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027

5.6 Threat of rivalry

• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027

5.7 Market condition

• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6.1 Market segments

• Exhibit 30: Chart on Therapy - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Therapy - Market share 2022-2027 (%)

6.2 Comparison by Therapy

• Exhibit 32: Chart on Comparison by Therapy
• Exhibit 33: Data Table on Comparison by Therapy

6.3 First line treatment - Market size and forecast 2022-2027

• Exhibit 34: Chart on First line treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on First line treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on First line treatment - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on First line treatment - Year-over-year growth 2022-2027 (%)

6.4 Second-line treatment - Market size and forecast 2022-2027

• Exhibit 38: Chart on Second-line treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Second-line treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Second-line treatment - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Second-line treatment - Year-over-year growth 2022-2027 (%)

6.5 Market opportunity by Therapy

• Exhibit 42: Market opportunity by Therapy ($ million)
• Exhibit 43: Data Table on Market opportunity by Therapy ($ million)

7.1 Market segments

• Exhibit 44: Chart on Route of Administration - Market share 2022-2027 (%)
• Exhibit 45: Data Table on Route of Administration - Market share 2022-2027 (%)

7.2 Comparison by Route of Administration

• Exhibit 46: Chart on Comparison by Route of Administration
• Exhibit 47: Data Table on Comparison by Route of Administration

7.3 Oral - Market size and forecast 2022-2027

• Exhibit 48: Chart on Oral - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Oral - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Oral - Year-over-year growth 2022-2027 (%)

7.4 Parenteral - Market size and forecast 2022-2027

• Exhibit 52: Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)

7.5 Market opportunity by Route of Administration

• Exhibit 56: Market opportunity by Route of Administration ($ million)
• Exhibit 57: Data Table on Market opportunity by Route of Administration ($ million)

8.1 Customer landscape overview

• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9.1 Geographic segmentation

• Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)

9.2 Geographic comparison

• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027

• Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 Europe - Market size and forecast 2022-2027

• Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.5 Asia - Market size and forecast 2022-2027

• Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)

9.6 Rest of World (ROW) - Market size and forecast 2022-2027

• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

9.7 US - Market size and forecast 2022-2027

• Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)

9.8 Canada - Market size and forecast 2022-2027

• Exhibit 83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Canada - Year-over-year growth 2022-2027 (%)

9.9 Germany - Market size and forecast 2022-2027

• Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.10 UK - Market size and forecast 2022-2027

• Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.11 China - Market size and forecast 2022-2027

• Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)

9.12 Market opportunity By Geographical Landscape

• Exhibit 99: Market opportunity By Geographical Landscape ($ million)
• Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges

• Exhibit 101: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11.1 Overview
11.2 Vendor landscape

• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption

• Exhibit 103: Overview on factors of disruption

11.4 Industry risks

• Exhibit 104: Impact of key risks on business

12.1 Vendors covered

• Exhibit 105: Vendors covered

12.2 Market positioning of vendors

• Exhibit 106: Matrix on vendor position and classification

12.3 Adaptive Biotechnologies Corp.

• Exhibit 107: Adaptive Biotechnologies Corp. - Overview
• Exhibit 108: Adaptive Biotechnologies Corp. - Product / Service
• Exhibit 109: Adaptive Biotechnologies Corp. - Key offerings

12.4 Almirall SA

• Exhibit 110: Almirall SA - Overview
• Exhibit 111: Almirall SA - Product / Service
• Exhibit 112: Almirall SA - Key news
• Exhibit 113: Almirall SA - Key offerings

12.5 Amgen Inc.

• Exhibit 114: Amgen Inc. - Overview
• Exhibit 115: Amgen Inc. - Product / Service
• Exhibit 116: Amgen Inc. - Key offerings

12.6 AMYRA Biotech AG

• Exhibit 117: AMYRA Biotech AG - Overview
• Exhibit 118: AMYRA Biotech AG - Product / Service
• Exhibit 119: AMYRA Biotech AG - Key offerings

12.7 BioLineRx Ltd.

• Exhibit 120: BioLineRx Ltd. - Overview
• Exhibit 121: BioLineRx Ltd. - Product / Service
• Exhibit 122: BioLineRx Ltd. - Key offerings

12.8 Bristol Myers Squibb Co.

• Exhibit 123: Bristol Myers Squibb Co. - Overview
• Exhibit 124: Bristol Myers Squibb Co. - Product / Service
• Exhibit 125: Bristol Myers Squibb Co. - Key news
• Exhibit 126: Bristol Myers Squibb Co. - Key offerings

12.9 Calypso Biotech BV

• Exhibit 127: Calypso Biotech BV - Overview
• Exhibit 128: Calypso Biotech BV - Product / Service
• Exhibit 129: Calypso Biotech BV - Key offerings

12.10 GlaxoSmithKline Plc

• Exhibit 130: GlaxoSmithKline Plc - Overview
• Exhibit 131: GlaxoSmithKline Plc - Business segments
• Exhibit 132: GlaxoSmithKline Plc - Key news
• Exhibit 133: GlaxoSmithKline Plc - Key offerings
• Exhibit 134: GlaxoSmithKline Plc - Segment focus

12.11 Glenmark Pharmaceuticals Ltd.

• Exhibit 135: Glenmark Pharmaceuticals Ltd. - Overview
• Exhibit 136: Glenmark Pharmaceuticals Ltd. - Product / Service
• Exhibit 137: Glenmark Pharmaceuticals Ltd. - Key offerings

12.12 ImmunogenX Inc.

• Exhibit 138: ImmunogenX Inc. - Overview
• Exhibit 139: ImmunogenX Inc. - Product / Service
• Exhibit 140: ImmunogenX Inc. - Key offerings

12.13 Johnson and Johnson

• Exhibit 141: Johnson and Johnson - Overview
• Exhibit 142: Johnson and Johnson - Business segments
• Exhibit 143: Johnson and Johnson - Key news
• Exhibit 144: Johnson and Johnson - Key offerings
• Exhibit 145: Johnson and Johnson - Segment focus

12.14 Precigen Inc.

• Exhibit 146: Precigen Inc. - Overview
• Exhibit 147: Precigen Inc. - Business segments
• Exhibit 148: Precigen Inc. - Key offerings
• Exhibit 149: Precigen Inc. - Segment focus

12.15 Sanofi

• Exhibit 150: Sanofi - Overview
• Exhibit 151: Sanofi - Business segments
• Exhibit 152: Sanofi - Key news
• Exhibit 153: Sanofi - Key offerings
• Exhibit 154: Sanofi - Segment focus

12.16 Takeda Pharmaceutical Co. Ltd.

• Exhibit 155: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 156: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 157: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 158: Takeda Pharmaceutical Co. Ltd. - Key offerings

12.17 Teva Pharmaceutical Industries Ltd.

• Exhibit 159: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 160: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 163: Teva Pharmaceutical Industries Ltd. - Segment focus

13.1 Scope of the report
13.2 Inclusions and exclusions checklist

• Exhibit 164: Inclusions checklist
• Exhibit 165: Exclusions checklist

13.3 Currency conversion rates for US$

• Exhibit 166: Currency conversion rates for US$

13.4 Research methodology

• Exhibit 167: Research methodology
• Exhibit 168: Validation techniques employed for market sizing
• Exhibit 169: Information sources

13.5 List of abbreviations

• Exhibit 170: List of abbreviations

Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 18: Historic Market Size - Data Table on global celiac diseases drugs market 2017 - 2021 ($ million)
Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibit 20: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
Exhibit 30: Chart on Therapy - Market share 2022-2027 (%)
Exhibit 31: Data Table on Therapy - Market share 2022-2027 (%)
Exhibit 32: Chart on Comparison by Therapy
Exhibit 33: Data Table on Comparison by Therapy
Exhibit 34: Chart on First line treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on First line treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on First line treatment - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on First line treatment - Year-over-year growth 2022-2027 (%)
Exhibit 38: Chart on Second-line treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Second-line treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Second-line treatment - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Second-line treatment - Year-over-year growth 2022-2027 (%)
Exhibit 42: Market opportunity by Therapy ($ million)
Exhibit 43: Data Table on Market opportunity by Therapy ($ million)
Exhibit 44: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 45: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibit 46: Chart on Comparison by Route of Administration
Exhibit 47: Data Table on Comparison by Route of Administration
Exhibit 48: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 52: Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibit 56: Market opportunity by Route of Administration ($ million)
Exhibit 57: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibit 83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
Exhibit 103: Overview on factors of disruption
Exhibit 104: Impact of key risks on business
Exhibit 105: Vendors covered
Exhibit 106: Matrix on vendor position and classification
Exhibit 107: Adaptive Biotechnologies Corp. - Overview
Exhibit 108: Adaptive Biotechnologies Corp. - Product / Service
Exhibit 109: Adaptive Biotechnologies Corp. - Key offerings
Exhibit 110: Almirall SA - Overview
Exhibit 111: Almirall SA - Product / Service
Exhibit 112: Almirall SA - Key news
Exhibit 113: Almirall SA - Key offerings
Exhibit 114: Amgen Inc. - Overview
Exhibit 115: Amgen Inc. - Product / Service
Exhibit 116: Amgen Inc. - Key offerings
Exhibit 117: AMYRA Biotech AG - Overview
Exhibit 118: AMYRA Biotech AG - Product / Service
Exhibit 119: AMYRA Biotech AG - Key offerings
Exhibit 120: BioLineRx Ltd. - Overview
Exhibit 121: BioLineRx Ltd. - Product / Service
Exhibit 122: BioLineRx Ltd. - Key offerings
Exhibit 123: Bristol Myers Squibb Co. - Overview
Exhibit 124: Bristol Myers Squibb Co. - Product / Service
Exhibit 125: Bristol Myers Squibb Co. - Key news
Exhibit 126: Bristol Myers Squibb Co. - Key offerings
Exhibit 127: Calypso Biotech BV - Overview
Exhibit 128: Calypso Biotech BV - Product / Service
Exhibit 129: Calypso Biotech BV - Key offerings
Exhibit 130: GlaxoSmithKline Plc - Overview
Exhibit 131: GlaxoSmithKline Plc - Business segments
Exhibit 132: GlaxoSmithKline Plc - Key news
Exhibit 133: GlaxoSmithKline Plc - Key offerings
Exhibit 134: GlaxoSmithKline Plc - Segment focus
Exhibit 135: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 136: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 137: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 138: ImmunogenX Inc. - Overview
Exhibit 139: ImmunogenX Inc. - Product / Service
Exhibit 140: ImmunogenX Inc. - Key offerings
Exhibit 141: Johnson and Johnson - Overview
Exhibit 142: Johnson and Johnson - Business segments
Exhibit 143: Johnson and Johnson - Key news
Exhibit 144: Johnson and Johnson - Key offerings
Exhibit 145: Johnson and Johnson - Segment focus
Exhibit 146: Precigen Inc. - Overview
Exhibit 147: Precigen Inc. - Business segments
Exhibit 148: Precigen Inc. - Key offerings
Exhibit 149: Precigen Inc. - Segment focus
Exhibit 150: Sanofi - Overview
Exhibit 151: Sanofi - Business segments
Exhibit 152: Sanofi - Key news
Exhibit 153: Sanofi - Key offerings
Exhibit 154: Sanofi - Segment focus
Exhibit 155: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 156: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 157: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 158: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibit 159: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 163: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibit 164: Inclusions checklist
Exhibit 165: Exclusions checklist
Exhibit 166: Currency conversion rates for US$
Exhibit 167: Research methodology
Exhibit 168: Validation techniques employed for market sizing
Exhibit 169: Information sources
Exhibit 170: List of abbreviations